Education
About Us
Working with TipRanks
Follow Us
Steven Hoerter Insider Profile
4 Followers
Steven Hoerter, Senior Vice President of Commercial Operations at Clovis Oncology, holds 42.77K shares in Deciphera Pharmaceuticals (Ticker: DCPH), holds 10.94K shares in Agios Pharma (Ticker: AGIO), holds 0.00 shares in Clovis Oncology (Ticker: CLVS). Most recently, Steven Hoerter Bought ― shares of Deciphera Pharmaceuticals on Aug 24, 2020 for an estimated value of $4.75K.
Steven Hoerter Clovis Oncology (CLVS)Senior Vice President of Commercial Operations
Clovis Oncology (CLVS)
Senior Vice President of Commercial Operations
Ranked #6,686 out of 78,624 Corporate Insiders
Profitable Transactions
7 out of 9 Profitable Transactions
Average Return
+23.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steven Hoerter holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 20, 2020 - Mar 20, 2021
Return:+67.70%
The most profitable trade made by Steven Hoerter
Steven Hoerter's Trading History
Clovis Oncology
Mar 09, 2015
Senior Vice President of Commercial Operations
Uninformative Sell
1.60M
$0.00
Agios Pharma
Mar 05, 2019
CCO
Informative Sell
670.05K
$488.73K
Ignyta Inc
―
―
―
―
Deciphera Pharmaceuticals
Aug 24, 2020
President & CEO, Director
Informative Buy
4.75K
$2.67M
Constellation Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Steven Hoerter's performance on stock
You May Also Like
Steven Hoerter insider profile FAQ
What is the percentage of profitable transactions made by Steven Hoerter?
The percentage of profitable transactions made by Steven Hoerter is 78%.
What is the average return per transaction made by Steven Hoerter?
The average return per transaction made by Steven Hoerter is 23.80%.
What stocks does Steven Hoerter hold?
Steven Hoerter holds: CLVS, AGIO, RXDX, DCPH, CNST stocks.
What was Steven Hoerter’s latest transaction?
Steven Hoerter latest transaction was an Informative Buy of $4.75K.
What was Steven Hoerter's most profitable transaction?
Steven Hoerter’s most profitable transaction was an Informative Buy of DCPH stock on March 20, 2020. The return on the trade was 67.70%.
What is Steven Hoerter's role in Clovis Oncology?
Steven Hoerter's role in Clovis Oncology is Senior Vice President of Commercial Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.